tiprankstipranks
Trending News
More News >
MedCap AB (DE:61MA)
:61MA
Germany Market

MedCap AB (61MA) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
MedCap AB’s (61MA) Moving Averages Convergence Divergence (MACD) indicator is 0.43, suggesting MedCap AB is a Buy.
MedCap AB’s (61MA) 20-Day exponential moving average is 39.35, while MedCap AB’s (61MA) share price is €39.05, making it a Sell.
MedCap AB’s (61MA) 50-Day exponential moving average is 38.07, while MedCap AB’s (61MA) share price is €39.05, making it a Buy.

MedCap AB (61MA) Pivot Points

Jun 06, 2025, 01:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
38.32
38.43
38.67
38.78
39.02
39.13
39.37
Fibonacci
38.43
38.57
38.65
38.78
38.92
39.00
39.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MedCap AB (61MA) Moving Averages

Jun 06, 2025, 01:13 PM
Period
Simple
Exponential
MA5
39.12Sell
39.14Sell
MA10
39.50Sell
39.44Sell
MA20
40.15Sell
39.35Sell
MA50
36.74Buy
38.07Buy
MA100
35.84Buy
38.38Buy
MA200
41.34Sell
41.24Sell
MedCap AB’s (61MA) 10-Day exponential moving average is 39.44, while MedCap AB’s (61MA) share price is €39.05, making it a Sell.
MedCap AB’s (61MA) 100-Day exponential moving average is 38.38, while MedCap AB’s (61MA) share price is €39.05, making it a Buy.
MedCap AB’s (61MA) stock price is €39.05 and MedCap AB’s (61MA) 50-day simple moving average is 36.74, creating a Buy signal.
MedCap AB’s (61MA) stock price is €39.05 and MedCap AB’s (61MA) 100-day simple moving average is 35.84, creating a Buy signal.
MedCap AB’s (61MA) stock price is €39.05 and MedCap AB’s (61MA) 200-day simple moving average is 41.34, creating a Sell signal.

MedCap AB (61MA) Technical Indicators

Jun 06, 2025, 01:13 PM
Name
Value
Implied Action
RSI (14)
49.55
Neutral
STOCH (9,6)
16.49
Buy
STOCHRSI (14)
14.10
Buy
MACD (12,26)
0.43
Buy
ADX (14)
24.17
Neutral
Williams %R
-84.91
Buy
CCI (14)
-117.74
Buy
ATR (14)
0.53
-
Ultimate Oscillator
38.54
Neutral
ROC
-4.30
Sell
MedCap AB’s (61MA) Relative Strength Index (RSI) is 49.55, creating a Neutral signal.
MedCap AB’s (61MA) Trend Strength Indicator (ADX) is 24.17, creating a Neutral signal.
MedCap AB’s (61MA) Commodity Channel Index (CCI) is -117.74, creating a Buy signal.
MedCap AB’s (61MA) Price Rate of Change (ROC) is -4.30, creating a Sell signal.

FAQ

Is 61MA a Buy, Hold, or Sell?
Based on 61MA’s technical indicators, 61MA is a Hold.
    What is 61MA’s RSI (14)?
    61MA’s RSI (14) is 49.55, which suggests 61MA is a Neutral.
      What is 61MA’s MACD?
      61MA’s MACD is 0.43, which suggests 61MA is a Buy.
        What is 61MA’s 5-day moving average?
        61MA’s 5-day moving average is 39.12, which suggests 61MA is a Sell.
          What is 61MA’s 20-day moving average?
          61MA 20-day moving average is 40.15, which suggests 61MA is a Sell.
            What is 61MA’s 50-day moving average?
            61MA’s 50-day moving average is 36.74, which suggests 61MA is a Buy.
              What is 61MA’s 200-day moving average?
              61MA’s 200-day moving average is 41.34, which suggests 61MA is a Sell.
                What is 61MA’s Williams % R (14)?
                61MA’s Williams % R (14) is -84.91, which suggests 61MA is a Buy.
                  What is 61MA’s CCI (14)?
                  61MA’s CCI (14) is -117.74, which suggests 61MA is a Buy.
                    What is the share price of MedCap AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis